Similar Survival, Less Toxicity With Decitabine vs Chemo in AML
For patients with acute myeloid leukemia, treatment with decitabine prior to stem cell transplantation had similar overall survival and much less toxicity compared with intensive chemotherapy.
Medscape Medical News
source https://www.medscape.com/viewarticle/975438?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/975438?src=rss
Comments
Post a Comment